Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCPK - Delayed Quote USD

Pro Medicus Limited (PMCUF)

Compare
123.43
0.00
(0.00%)
At close: April 2 at 4:00:00 PM EDT
Loading Chart for PMCUF
  • Previous Close 0.00
  • Open 130.00
  • Bid 120.09 x 40000
  • Ask 129.00 x 900
  • Day's Range 130.00 - 130.00
  • 52 Week Range 65.00 - 187.00
  • Volume 100
  • Avg. Volume 154
  • Market Cap (intraday) 12.895B
  • Beta (5Y Monthly) 0.47
  • PE Ratio (TTM) 209.21
  • EPS (TTM) 0.59
  • Earnings Date Feb 12, 2025
  • Forward Dividend & Yield 0.32 (0.26%)
  • Ex-Dividend Date Feb 27, 2025
  • 1y Target Est --

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company was incorporated in 1983 and is headquartered in Richmond, Australia.

www.promed.com.au

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: PMCUF

View More

Performance Overview: PMCUF

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

PMCUF
20.50%
S&P/ASX 200 [XJO] (^AXJO)
3.66%

1-Year Return

PMCUF
79.65%
S&P/ASX 200 [XJO] (^AXJO)
0.55%

3-Year Return

PMCUF
241.20%
S&P/ASX 200 [XJO] (^AXJO)
4.89%

5-Year Return

PMCUF
383.19%
S&P/ASX 200 [XJO] (^AXJO)
55.11%

Compare To: PMCUF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PMCUF

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    13.07B

  • Enterprise Value

    12.95B

  • Trailing P/E

    210.59

  • Forward P/E

    116.28

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    112.17

  • Price/Book (mrq)

    92.98

  • Enterprise Value/Revenue

    111.62

  • Enterprise Value/EBITDA

    146.66

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    53.25%

  • Return on Assets (ttm)

    32.90%

  • Return on Equity (ttm)

    51.53%

  • Revenue (ttm)

    184.58M

  • Net Income Avi to Common (ttm)

    98.29M

  • Diluted EPS (ttm)

    0.59

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    182.33M

  • Total Debt/Equity (mrq)

    0.82%

  • Levered Free Cash Flow (ttm)

    84.17M

Research Analysis: PMCUF

View More

Company Insights: PMCUF

Research Reports: PMCUF

View More

People Also Watch